|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Diet & Human Performance Laboratory, Beltsville Human Nutrition Research Center, Agricultural Research Service, US Department of Agriculture, Beltsville, MD
Background: Barley has high amounts of soluble fiber but is not extensively consumed in the US diet.
Objective: This study investigated whether consumption of barley would reduce cardiovascular disease risk factors comparably with that of other sources of soluble fiber.
Design: Mildly hypercholesterolemic subjects (9 postmenopausal women, 9 premenopausal women, and 7 men) consumed controlled American Heart Association Step 1 diets for 17 wk. After a 2-wk adaptation period, whole-grain foods containing 0, 3, or 6 g ß-glucan/d from barley were included in the Step 1 diet menus. Diets were consumed for 5 wk each and were fed in a Latin-square design. Fasting blood samples were collected twice weekly.
Results: Total cholesterol was significantly lower when the diet contained 3 or 6 g ß-glucan/d from barley than when it contained no ß-glucan; the greatest change occurred in the men and postmenopausal women. HDL and triacylglycerol concentrations did not differ with the 3 amounts of dietary ß-glucan. Large LDL and small VLDL fractions and mean LDL particle size significantly decreased when whole grains were incorporated into the 3 diets. Large LDL and large and intermediate HDL fractions were significantly higher, mean LDL particle size was significantly greater, and intermediate VLDL fractions were significantly lower in the postmenopausal women than in the other 2 groups. A group-by-diet interaction effect was observed on LDL fractions and small LDL particle size.
Conclusion: The addition of barley to a healthy diet may be effective in lowering total and LDL cholesterol in both men and women.
Key Words: Barley ß-glucans whole grains cholesterol triacylglycerols lipoprotein fractions
This article has been cited by other articles:
![]() |
F. F. De Moura, K. D. Lewis, and M. C. Falk Applying the FDA Definition of Whole Grains to the Evidence for Cardiovascular Disease Health Claims J. Nutr., November 1, 2009; 139(11): 2220S - 2226S. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Talati, W. L. Baker, M. S. Pabilonia, C. M. White, and C. I. Coleman The Effects of Barley-Derived Soluble Fiber on Serum Lipids Ann. Fam. Med, March 1, 2009; 7(2): 157 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Timm and J. L. Slavin Dietary Fiber and the Relationship to Chronic Diseases American Journal of Lifestyle Medicine, June 1, 2008; 2(3): 233 - 240. [Abstract] [PDF] |
||||
![]() |
K. N. Smith, K. M. Queenan, W. Thomas, R. G. Fulcher, and J. L. Slavin Physiological Effects of Concentrated Barley {beta}-Glucan in Mildly Hypercholesterolemic Adults J. Am. Coll. Nutr., June 1, 2008; 27(3): 434 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Ames and C. R. Rhymer Issues Surrounding Health Claims for Barley J. Nutr., June 1, 2008; 138(6): 1237S - 1243S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shrestha, H. C. Freake, M. M. McGrane, J. S. Volek, and M. L. Fernandez A Combination of Psyllium and Plant Sterols Alters Lipoprotein Metabolism in Hypercholesterolemic Subjects by Modifying the Intravascular Processing of Lipoproteins and Increasing LDL Uptake J. Nutr., May 1, 2007; 137(5): 1165 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shrestha, J. S. Volek, J. Udani, R. J.Wood, C. M. Greene, D. Aggarwal, J. H. Contois, B. Kavoussi, and M. L. Fernandez A Combination Therapy Including Psyllium and Plant Sterols Lowers LDL Cholesterol by Modifying Lipoprotein Metabolism in Hypercholesterolemic Individuals J. Nutr., October 1, 2006; 136(10): 2492 - 2497. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Griel, E. H. Ruder, and P. M. Kris-Etherton The Changing Roles of Dietary Carbohydrates: From Simple to Complex Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 1958 - 1965. [Abstract] [Full Text] [PDF] |
||||
![]() |
Minerva BMJ, February 12, 2005; 330(7487): E339 - E339. [Full Text] [PDF] |
||||
![]() |
Minerva BMJ, November 27, 2004; 329(7477): 1296 - 1296. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |